Barclays analyst Adrienne Yih maintains Nike (NYSE:NKE) with a Overweight and raises the price target from $185 to $195.
ATAI Life Sciences Q2 EPS $(0.37) Misses $0.01 Estimate
ATAI Life Sciences (NASDAQ:ATAI) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $0.01 by 3800 percent.